Document the Path to Wound Healing with MolecuLight i:XTM

Clinical-Synopsis

Clinical Synopsis:

Abdominoplasty (“tummy tuck”) is one of the most commonly performed aesthetic procedures and associated with many complications, including infection, at a rate of 3-10%.1 In this case, a 41-year-old woman experienced dehiscence and surgical site infection after an abdominoplasty, and was referred to a wound care specialist. Red fluorescence, as visualized on the MolecuLight i:X, confirmed the presence of bacteria2 at the periphery of the wound.

To eliminate the bacterial load, the periphery of the wound was vigorously cleaned, and silver-based antimicrobials were applied in conjunction with negative pressure wound therapy. Follow-up care was provided and by Day 3, imaging indicated that the bacterial load was reduced and the size of the wound had decreased. With rapid feedback on surface area reduction and the effectiveness of therapy, a less onerous treatment was planned and indeed the wound achieved a 54.8% reduction in surface area in 4 weeks, indicating a rapidly healing path.

Timeline

Path to Wound Healing Timeline

Bacteria Visualization

Red fluorescing bacteria visualized by the MolecuLight i:X (Fig. 1) prompted a change in treatment plan to reduce the bacterial load. Red fluorescing bacteria decreased after vigorous cleaning (Fig. 2). Wound measurement was captured to document wound size prior to treatment (Fig. 3).

DAY 1

day1

Treatment Plan Effectiveness

Absence of red bacterial fluorescence and decrease in wound size demonstrated treatment effectiveness, and as a result, the clinician reduced the frequency of dressing changes.

DAY 3

day3

Decreased Wound Size

Wound measurements taken during follow-up visits confirmed the size of the wound was decreasing steadily. By Week 4, the wound achieved a 54.8% reduction in surface area, indicating a rapidly healing path.

w234

patient-icon_dark-grey-copy

Patient Condition

Wound Etiology
  • Abdominoplasty (surgical site infection)
Patient Demographics
  • Female, 41 years old
Patient's General Care Paradigm
  • Silver based antimicrobials in conjunction with NPWT
Clinician Stated Utility of the Moleculight i:X
  • Rapid feedback on cleaning and treatment effectiveness
  • Document wound size over time

nurse-icon-copy

Practitioner’s Bio

Rose Raizman, RN-EC, MSc, with over 19 years of experience, leads the Save Our Skin (SOS) team at Scarborough & Rouge Hospital located in Toronto, Canada, to combat pressure ulcers of hospital inpatients. She also oversees the wound care clinic for inpatients and outpatients.

Testimonial

Testimonial

“The decreased red bacterial fluorescence after vigorous cleaning gave me confidence that the bioburden could be managed with dressing changes that decreased in frequency. Furthermore, using the wound measurement feature it was easy to calculate that the wound size had decreased by over 50% in just 4 weeks, meaning that the treatment was effective and the wound was indeed on a healing trajectory.”

— Rose Raizman RN-EC, MSc

References:
Images provided by Rose Raizman, RN-EC, MSc, Scarborough & Rouge Hospital, ON, Canada
MolecuLight Clinical Case 0066.

  1. Winocour J, et al. Abdominoplasty: Risk Factors, Complication Rates, and Safety of Combined Procedures. Plast Reconstr Surg. 2015 Nov;136(5):597e-606e.
  2. Rennie MY, et al. J Wound Care. 2017 Aug 2;26(8):452-460.

Download PDF